Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions - PubMed (original) (raw)
Review
Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions
Bianca Marchetti et al. Brain Res Brain Res Rev. 2005 Apr.
Abstract
Inflammation and oxidative stress have been closely associated with the pathogenesis of neurodegenerative disorders, including Parkinson's disease (PD). The expression of inducible nitric oxide synthase (iNOS) in astrocytes and microglia and the production of large amounts of nitric oxide (NO) are thought to contribute to dopaminergic neuron demise. Increasing evidence, however, indicates that activated astroglial cells play key roles in neuroprotection and can promote recovery of CNS functions. Endogenous glucocorticoids (GCs) via glucocorticoid receptors (GRs) exert potent anti-inflammatory and immunosuppressive effects and are key players in protecting the brain against stimulation of innate immunity. Here we review our work showing that exposure to a dysfunctional GR from early embryonic life in transgenic (Tg) mice expressing GR antisense RNA represents a key vulnerability factor in the response of nigrostriatal dopaminergic neurons to the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and further report that exacerbation of dopaminergic neurotoxicity with no recovery is determined by failure of astroglia to exert neuroprotective effects. Aberrant iNOS gene expression and increased glia vulnerability to cell death characterized the response of GR-deficient mice to stimulation of innate immunity. More importantly, GR-deficient glial cells failed to protect fetal dopaminergic neurons against oxidative stress-induces cell death, whereas wild-type glia afforded neuroprotection. Thus, lack of iNOS/NO regulation by GCs can program an aberrant GR-NO crosstalk in turn responsible for loss of astroglia neuroprotective function in response to stimulation of innate immunity, pointing to glia and efficient GR-NO dialogue as pivotal factors orchestrating neuroprotection in experimental parkinsonism.
Similar articles
- Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide.
Morale MC, Serra PA, Delogu MR, Migheli R, Rocchitta G, Tirolo C, Caniglia S, Testa N, L'Episcopo F, Gennuso F, Scoto GM, Barden N, Miele E, Desole MS, Marchetti B. Morale MC, et al. FASEB J. 2004 Jan;18(1):164-6. doi: 10.1096/fj.03-0501fje. Epub 2003 Nov 20. FASEB J. 2004. PMID: 14630699 - Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
Marchetti B, Serra PA, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Cioni S, Gennuso F, Rocchitta G, Desole MS, Mazzarino MC, Miele E, Morale MC. Marchetti B, et al. Ann N Y Acad Sci. 2005 Dec;1057:296-318. doi: 10.1196/annals.1356.023. Ann N Y Acad Sci. 2005. PMID: 16399902 Review. - Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B. Morale MC, et al. Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5. Neuroscience. 2006. PMID: 16337092 Review. - Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Tian YY, An LJ, Jiang L, Duan YL, Chen J, Jiang B. Tian YY, et al. Life Sci. 2006 Dec 23;80(3):193-9. doi: 10.1016/j.lfs.2006.09.010. Epub 2006 Sep 20. Life Sci. 2006. PMID: 17049947 - Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K, Ischiropoulos H, Przedborski S. Tieu K, et al. IUBMB Life. 2003 Jun;55(6):329-35. doi: 10.1080/1521654032000114320. IUBMB Life. 2003. PMID: 12938735 Review.
Cited by
- Chronic restraint stress impairs cognition via modulating HDAC2 expression.
Wu J, Liu C, Zhang L, He B, Shi WP, Shi HL, Qin C. Wu J, et al. Transl Neurosci. 2021 Apr 29;12(1):154-163. doi: 10.1515/tnsci-2020-0168. eCollection 2021 Jan 1. Transl Neurosci. 2021. PMID: 33986954 Free PMC article. - Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.
Machado A, Herrera AJ, Venero JL, Santiago M, de Pablos RM, Villarán RF, Espinosa-Oliva AM, Argüelles S, Sarmiento M, Delgado-Cortés MJ, Mauriño R, Cano J. Machado A, et al. ISRN Neurol. 2011;2011:476158. doi: 10.5402/2011/476158. Epub 2011 Apr 17. ISRN Neurol. 2011. PMID: 22389821 Free PMC article. - Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease.
Smith LK, Jadavji NM, Colwell KL, Katrina Perehudoff S, Metz GA. Smith LK, et al. Eur J Neurosci. 2008 Apr;27(8):2133-46. doi: 10.1111/j.1460-9568.2008.06177.x. Eur J Neurosci. 2008. PMID: 18412632 Free PMC article. - Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair.
Marchetti B, L'Episcopo F, Morale MC, Tirolo C, Testa N, Caniglia S, Serapide MF, Pluchino S. Marchetti B, et al. Eur J Neurosci. 2013 May;37(10):1550-63. doi: 10.1111/ejn.12166. Epub 2013 Mar 5. Eur J Neurosci. 2013. PMID: 23461676 Free PMC article. Review. - Wnt your brain be inflamed? Yes, it Wnt!
Marchetti B, Pluchino S. Marchetti B, et al. Trends Mol Med. 2013 Mar;19(3):144-56. doi: 10.1016/j.molmed.2012.12.001. Epub 2013 Jan 9. Trends Mol Med. 2013. PMID: 23312954 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous